Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Maloney, DG' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 46 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Maris, M; Sandmaier, BM; Maloney, DG; McSweeney, PA; Woolfrey, A; Chauncey, T; Shizuru, J; Niederwieser, D; Blume, KG; Forman, S; Storb, R
      Non-myeloablative hematopoietic stem cell transplantation

      TRANSFUSION CLINIQUE ET BIOLOGIQUE
    2. Maris, M; Woolfrey, A; McSweeney, PA; Sandmaier, BM; Nash, RA; Georges, G; Maloney, DG; Molina, A; Chauncey, T; Yu, C; Zaucha, JM; Blume, KG; Shizuru, J; Niederwieser, D; Storb, R
      Nonmyeloablative hematopoietic stem cell transplantation: Transplantation for the 21(st) century

      FRONTIERS IN BIOSCIENCE
    3. Maloney, DG
      Mechanism of action of rituximab

      ANTI-CANCER DRUGS
    4. Maloney, DG
      Immunotherapy for non-Hodgkin's lymphoma - The Vose article reviewed

      ONCOLOGY-NEW YORK
    5. Gutierrez-Delgado, F; Maloney, DG; Press, OW; Golden, J; Holmberg, LA; Maziarz, RT; Hooper, H; Buckner, CD; Appelbaum, FR; Bensinger, WI
      Autologous stem cell transplantation for non-Hodgkin's lymphoma: comparison of radiation-based and chemotherapy-only preparative regimens

      BONE MARROW TRANSPLANTATION
    6. Gopal, AK; Gooley, TA; Golden, JB; Maloney, DG; Bensinger, WI; Petersdorf, SH; Appelbaum, FR; Press, OW
      Efficacy of high-dose therapy and autologous hematopoietic stem cell transplantation for non-Hodgkin's lymphoma in adults 60 years of age and older

      BONE MARROW TRANSPLANTATION
    7. Maloney, DG
      Monoclonal antibody therapy for hematologic malignancies: Prospects for anintegrated approach (vol 37, pg 17, 2000)

      SEMINARS IN HEMATOLOGY
    8. Storek, J; Wells, D; Dawson, MA; Storer, B; Maloney, DG
      Factors influencing B lymphopoiesis after allogeneic hematopoietic cell transplantation

      BLOOD
    9. Storek, J; Joseph, A; Espino, G; Dawson, MA; Douek, DC; Sullivan, KM; Flowers, MED; Martin, P; Mathioudakis, G; Nash, RA; Storb, R; Appelbaum, FR; Maloney, DG
      Immunity of patients surviving 20 to 30 years after allogeneic or syngeneic bone marrow transplantation

      BLOOD
    10. Weissinger, F; Sandmaier, BM; Maloney, DG; Bensinger, WI; Gooley, T; Storb, R
      Decreased transfusion requirements for patients receiving nonmyeloablativecompared with conventional peripheral blood stem cell transplants from HLA-identical siblings

      BLOOD
    11. Storek, J; Dawson, MA; Storer, B; Stevens-Ayers, T; Maloney, DG; Marr, KA; Witherspoon, RP; Bensinger, W; Flowers, MED; Martin, P; Storb, R; Appelbaum, FR; Boeckh, M
      Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation

      BLOOD
    12. McSweeney, PA; Niederwieser, D; Shizuru, JA; Sandmaier, BM; Molina, AJ; Maloney, DG; Chauncey, TR; Gooley, TA; Hegenbart, U; Nash, RA; Radich, J; Wagner, JL; Minor, S; Appelbaum, FR; Bensinger, WI; Bryant, E; Flowers, MED; Georges, GE; Grumet, FC; Kiem, HP; Torok-Storb, B; Yu, G; Blume, KG; Storb, RF
      Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

      BLOOD
    13. Davis, TA; Maloney, DG; Grillo-Lopez, AJ; White, CA; Williams, ME; Weiner, GJ; Dowden, S; Levy, R
      Combination immunotherapy of relapsed or refractory low-grade or follicular non-Hodgkin's lymphoma with rituximab and interferon-alpha-2a

      CLINICAL CANCER RESEARCH
    14. Davis, TA; Grillo-Lopez, AJ; White, CA; McLaughlin, P; Czuczman, MS; Link, BK; Maloney, DG; Weaver, RL; Rosenberg, J; Levy, R
      Rituximab anti-CD20 monoclonal antibody therapy in non-Hodgkin's lymphoma:Safety and efficacy of re-treatment

      JOURNAL OF CLINICAL ONCOLOGY
    15. Storb, R; McSweeney, PA; Sandmaier, BM; Nash, RA; Georges, G; Maloney, DG; Molina, A; Chauncey, T; Yu, C; Zaucha, JM; Blume, KG; Shizuru, J; Niederwieser, D
      Allogeneic hematopoietic stem cell transplantation: From the nuclear age into the twenty-first century

      TRANSPLANTATION PROCEEDINGS
    16. Maloney, DG
      Monoclonal antibodies in lymphoid neoplasia: Principles for optimal combined therapy

      SEMINARS IN HEMATOLOGY
    17. Press, OW; Eary, JF; Gooley, T; Gopal, AK; Liu, S; Rajendran, JG; Maloney, DG; Petersdorf, S; Bush, SA; Durack, LD; Martin, PJ; Fisher, DR; Wood, B; Borrow, JW; Porter, B; Smith, JP; Matthews, DC; Appelbaum, FR; Bernstein, ID
      A phase I/II trial of iodine-131-tositumomab (anti-CD20), etoposide, cyclophosphamide, and autologous stem cell transplantation for relapsed B-cell lymphomas

      BLOOD
    18. Storek, J; Dawson, MA; Maloney, DG
      Normal T, B, and NK cell counts in healthy donors at 1 year after blood stem cell harvesting

      BLOOD
    19. Storek, J; Dawson, MA; Maloney, DG
      Normal anti-CD3-stimulated proliferation of CD4 T cells at one year after allogeneic marrow transplantation

      TRANSPLANT IMMUNOLOGY
    20. Maloney, DG
      Antibody therapy has arrived. Now where does it fit?

      ANNALS OF ONCOLOGY
    21. Davis, TA; White, CA; Grillo-Lopez, AJ; Velasquez, WS; Link, B; Maloney, DG; Dillman, RO; Williams, ME; Mohrbacher, A; Weaver, R; Dowden, S; Levy, R
      Single-agent monoclonal antibody efficacy in bulky non-Hodgkin's lymphoma:Results of a phase II trial of rituximab

      JOURNAL OF CLINICAL ONCOLOGY
    22. Maloney, DG
      Preclinical and phase I and II trials of rituximab

      SEMINARS IN ONCOLOGY
    23. Maloney, DG; Donovan, K; Hamblin, TJ
      Antibody therapy for treatment of multiple myeloma

      SEMINARS IN HEMATOLOGY
    24. Gopal, AK; Schuetze, SH; Maloney, DG; Weiden, PL
      Large cell non-Hodgkin's lymphoma and Hodgkin's disease arising synchronously in a patient with chronic lymphocytic leukemia: Importance of immunocytochemistry

      BLOOD
    25. Holmberg, LA; Boeckh, M; Hooper, H; Leisenring, W; Rowley, S; Heimfeld, S; Press, O; Maloney, DG; McSweeney, P; Corey, L; Maziarz, RT; Appelbaum, FR; Bensinger, W
      Increased incidence of cytomegalovirus disease after autologous CD34-selected peripheral blood stem cell transplantation

      BLOOD
    26. MALONEY DG; PRESS OW
      NEWER TREATMENTS FOR NON-HODGKINS-LYMPHOMA - MONOCLONAL-ANTIBODIES

      Oncology
    27. McLaughlin, P; White, CA; Grillo-Lopez, AJ; Maloney, DG
      Clinical status and optimal use of rituximab for B-cell lymphomas

      ONCOLOGY-NEW YORK
    28. MALONEY DG; DAVIS T; LEVY R
      PERIPHERAL T-CELL LYMPHOMA AFTER ANTI-CD20 ANTIBODY THERAPY - IN REPLY (VOL 16, PG 1636, 1998)

      Journal of clinical oncology
    29. MALONEY DG; DAVIS T; LEVY R
      PERIPHERAL T-CELL LYMPHOMA AFTER ANTI-CD20 ANTIBODY THERAPY - IN REPLY

      Journal of clinical oncology
    30. LIU SY; EARY JF; PETERSDORF SH; MARTIN PJ; MALONEY DG; APPELBAUM FR; MATTHEWS DC; BUSH SA; DURACK LD; FISHER DR; GOOLEY TA; BERNSTEIN ID; PRESS OW
      FOLLOW-UP OF RELAPSED B-CELL LYMPHOMA PATIENTS TREATED WITH IODINE-131-LABELED ANTI-CD20 ANTIBODY AND AUTOLOGOUS STEM-CELL RESCUE

      Journal of clinical oncology
    31. STOREK J; DAWSON MA; MALONEY DG
      COMPARISON OF 2 FLOW CYTOMETRIC METHODS ENUMERATING CD4 T-CELLS AND CD8 T-CELLS

      Cytometry
    32. DAVIS TA; MALONEY DG; CZERWINSKI DK; LILES TM; LEVY R
      ANTIIDIOTYPE ANTIBODIES CAN INDUCE LONG-TERM COMPLETE REMISSIONS IN NON-HODGKINS-LYMPHOMA WITHOUT ERADICATING THE MALIGNANT CLONE

      Blood
    33. MALONEY DG; GRILLOLOPEZ AJ; BODKIN DJ; WHITE CA; LILES TM; ROYSTON I; VARNS C; ROSENBERG J; LEVY R
      IDEC-C2B8 - RESULTS OF A PHASE-I MULTIPLE-DOSE TRIAL IN PATIENTS WITHRELAPSED NON-HODGKINS-LYMPHOMA

      Journal of clinical oncology
    34. MALONEY DG; GRILLOLOPEZ AJ; WHITE CA; BODKIN D; SCHILDER RJ; NEIDHART JA; JANAKIRAMAN N; FOON KA; LILES TM; DALLAIRE BK; WEY K; ROYSTON I; DAVIS T; LEVY R
      IDEC-C2B8 (RITUXIMAB) ANTI-CD20 MONOCLONAL-ANTIBODY THERAPY IN PATIENTS WITH RELAPSED LOW-GRADE NON-HODGKINS-LYMPHOMA

      Blood
    35. STOREK J; GOOLEY T; SIADAK M; BENSINGER WI; MALONEY DG; CHAUNCEY TR; FLOWERS M; SULLIVAN KM; WITHERSPOON RP; ROWLEY SD; HANSEN JA; STORB R; APPELBAUM FR
      ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION MAY BE ASSOCIATED WITH A HIGH-RISK OF CHRONIC GRAFT-VERSUS-HOST DISEASE

      Blood
    36. DAVIS T; LEVY R; WHITE CA; MALONEY DG; LINK B; VELASQUEZ WS; VARNS C; GARDNER C; GRILLOLOPEZ AJ
      RETREATMENTS WITH RITUXAN(TM) (RITUXIMAB, IDEC-C2B8) HAVE SIGNIFICANTEFFICACY, DO NOT CAUSE HAMA, AND ARE A VIABLE MINIMALLY TOXIC ALTERNATIVE IN RELAPSED OR REFRACTORY NON-HODGKINS-LYMPHOMA (NHL)

      Blood
    37. STOREK J; WITHERSPOON RP; MALONEY DG; CHAUNCEY TR; STORB R
      IMPROVED RECONSTITUTION OF CD4 T-CELLS AND B-CELLS BUT WORSENED RECONSTITUTION OF SERUM IGG LEVELS AFTER ALLOGENEIC TRANSPLANTATION OF BLOOD STEM-CELLS INSTEAD OF MARROW

      Blood
    38. BENSINGER WI; ROWLEY SD; DEMIRER T; LILLEBY K; SCHIFFMAN K; CLIFT RA; APPELBAUM FR; FEFER A; BARNETT T; STORB R; CHAUNCEY T; MAZIARZ RT; KLARNET J; MCSWEENEY P; HOLMBERG L; MALONEY DG; WEAVER CH; BUCKNER CD
      HIGH-DOSE THERAPY FOLLOWED BY AUTOLOGOUS HEMATOPOIETIC STEM-CELL INFUSION FOR PATIENTS WITH MULTIPLE-MYELOMA

      Journal of clinical oncology
    39. BRUNVAND MW; BENSINGER WI; SOLL E; WEAVER CH; ROWLEY SD; APPELBAUM FR; LILLEBY K; CLIFT RA; GOOLEY TA; PRESS OW; FEFER A; STORB R; SANDERS JE; MARTIN PL; CHAUNCEY T; MAZIARZ RT; ZUCKERMAN N; MONTGOMERY P; DORN R; WEIDEN PL; DEMIRER T; HOLMBERG LA; SCHIFFMAN K; MCSWEENEY PA; MALONEY DG; BUCKNER CD
      HIGH-DOSE FRACTIONATED TOTAL-BODY IRRADIATION, ETOPOSIDE AND CYCLOPHOSPHAMIDE FOR TREATMENT OF MALIGNANT-LYMPHOMA - COMPARISON OF AUTOLOGOUS BONE-MARROW AND PERIPHERAL-BLOOD STEM-CELLS

      Bone marrow transplantation
    40. DOPFMER UR; MALONEY DG; GAYNOR PA; RATCLIFFE RMH; DOPFMER S
      PRILOCAINE 3 PERCENT IS SUPERIOR TO A MIXTURE OF BUPIVACAINE AND LIGNOCAINE FOR PERIBULBAR ANESTHESIA

      British Journal of Anaesthesia
    41. MALONEY DG; SMITH B; APPELBAUM FR
      THE ANTITUMOR EFFECT OF MONOCLONAL ANTI-CD20 ANTIBODY (MAB) THERAPY INCLUDES DIRECT ANTIPROLIFERATIVE ACTIVITY AND INDUCTION OF APOPTOSIS IN CD20 POSITIVE NON-HODGKINS-LYMPHOMA (NHL) CELL-LINES

      Blood
    42. MALONEY DG; GRILLOLOPEZ AJ; BODKIN D; WHITE C; FOON K; SCHILDER RJ; NEIDHART J; JANAKIRAMAN N; WALDICHUK C; DAVIS T; DALLAIRE BK; ROYSTON I; LEVY R
      IDEC-C2B8 ANTI-CD20 ANTIBODY - RESULTS OF LONG-TERM FOLLOW-UP OF RELAPSED NHL PHASE-II TRIAL PATIENTS

      Blood
    43. MALONEY DG; LILES TM; CZERWINSKI DK; WALDICHUK C; ROSENBERG J; GRILLOLOPEZ A; LEVY R
      PHASE-I CLINICAL-TRIAL USING ESCALATING SINGLE-DOSE INFUSION OF CHIMERIC ANTI-CD20 MONOCLONAL-ANTIBODY (IDEC-C2B8) IN PATIENTS WITH RECURRENT B-CELL LYMPHOMA

      Blood
    44. MALONEY DG; BODKIN D; GRILLOLOPEZ AJ; WHITE C; FOON K; SCHILDER R; NEIDHART J; JANAKIRAMAN N; WALDICHUK C; VARNS C; ROYSTON I; LEVY R
      IDEC-C2B8 - FINAL REPORT ON A PHASE-II TRIAL IN RELAPSED NON-HODGKINS-LYMPHOMA

      Blood
    45. VUIST WMJ; LEVY R; MALONEY DG
      LYMPHOMA REGRESSION INDUCED BY MONOCLONAL ANTIIDIOTYPIC ANTIBODIES CORRELATES WITH THEIR ABILITY TO INDUCE IG SIGNAL-TRANSDUCTION AND IS NOT PREVENTED BY TUMOR EXPRESSION OF HIGH-LEVELS OF BCL-2 PROTEIN

      Blood
    46. MALONEY DG; LILES TM; CZERWINSKI DK; WALDICHUK C; ROSENBERG J; GRILLOLOPEZ A; LEVY R
      PHASE-I CLINICAL-TRIAL USING ESCALATING SINGLE-DOSE INFUSION OF CHIMERIC ANTI-CD20 MONOCLONAL-ANTIBODY (IDEC-C2B8) IN PATIENTS WITH RECURRENT B-CELL LYMPHOMA

      Blood


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 19/10/20 alle ore 23:54:37